Viewing StudyNCT01300793



Ignite Creation Date: 2024-05-05 @ 11:20 PM
Last Modification Date: 2024-10-26 @ 10:31 AM
Study NCT ID: NCT01300793
Status: TERMINATED
Last Update Posted: 2012-09-26
First Post: 2009-09-24

Brief Title: Study of Standard-Dose Rituximab Ifosfamide Carboplatin and Etoposide
Sponsor: University of California San Francisco
Organization: University of California San Francisco

Conditions & Keywords Data

Conditions:
Name
B-cell Lymphoma
Non-Hodgkins Lymphoma
Keywords:
Name View
V-RICE View
Relapsed NHL View
Primary Refractory NHL View